Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating VIA Disc NP, a non-surgical treatment designed to supplement the nucleus pulposus tissue in degenerated intervertebral discs. This randomized, sham-controlled, multi-center, double-blind clinical trial includes participants with lumbar discogenic pain related to degenerative disc disease DDD. The study aims to assess the safety and effectiveness of this treatment for managing moderate to severe disc-related back pain. Participants will receive one VIA Disc NP treatment injected into each affected disc level, with up to two levels treated per person. After an initial open-label roll-in period, participants are randomized in a 21 ratio to receive either the VIA Disc NP injection or a sham procedure that mimics the treatment without injecting any material. Participants in the sham group who still have symptoms after 12 months may cross over to receive the VIA Disc NP treatment and continue follow-up for another 12 months. During the study, participants will be closely monitored through scheduled visits to evaluate pain reduction using the Visual Analog Scale VAS and to record any treatment-related adverse events over 12 months. The main outcomes include the proportion of participants achieving meaningful pain improvement and the frequency of adverse events related to the treatment. Follow-up assessments and monitoring will continue throughout the study duration, which extends up to the study completion date in October 2028.
Actively Recruiting
This research aims to review anonymous medical records to study the clinical outcomes of various treatments for chronic pain. It is a retrospective, multi-center data review that includes multiple patient groups to evaluate different treatment approaches. The study focuses on patients who have been implanted with or are eligible for spinal cord stimulation systems or other treatments such as radiofrequency RF or intrathecal drug delivery systems IDS. The study compares different treatment methods, including Boston Scientific devices and non-Boston Scientific systems like spinal cord stimulation, RF, and IDS. It involves two groups patients eligible for these treatments and those who have received a prior treatment followed by a different chronic pain therapy. This evaluation uses de-identified data collected from medical charts without direct patient intervention. Participants involvement consists of reviewing their past medical data over approximately two years. Researchers will measure the responder rate, which indicates the effectiveness of the treatments through the study period. Since this is a data review, there are no active treatments or visits required, and patient privacy is maintained throughout the study.